The Unitary Patent system, which became operational on 1 June 2023 alongside the Unified Patent Court, introduced a new option for European patent applicants at the point of grant: instead of validating a European Patent (EP) nationally in each desired country, applicants can request unitary effect, creating a single patent right covering all EU participating member states in a single step. This is a fundamental change in the structure of European patent protection, but it does not eliminate the traditional national validation route, and the choice between them involves strategic considerations that are not always straightforward.
The European Patent Office (EPO) examines and grants European Patents under the European Patent Convention (EPC). The EPC is not an EU instrument; it covers 39 contracting states including EU member states and non-EU states such as Switzerland, Norway, the UK, and Turkey. The Unitary Patent system is an EU instrument operating on top of the EPC: once an EP is granted, the applicant can request unitary effect for the EU participating states, while separately validating in non-EU EPC states if desired. The UK, Switzerland, Norway, and Turkey are not part of the Unitary Patent system and require separate national validation regardless of the unitary effect request.
A Unitary Patent provides protection in all EU member states that have ratified the Unified Patent Court Agreement at the time of registration. As of mid-2025, this covers 18 EU member states. Spain and Croatia are notable EU member states that have not ratified the UPC Agreement and are therefore not covered by the Unitary Patent; applicants wishing to cover Spain or Croatia must validate nationally in those countries even if they request unitary effect.
The renewal fee for a Unitary Patent is paid to the EPO as a single annual fee and is calculated at a level comparable to the cost of renewing in the four most-validated countries under the traditional system. For applicants who previously validated in only a small number of countries, the Unitary Patent may be more expensive per covered country than targeted national validation. For applicants seeking broad European coverage, the cost comparison typically favours the Unitary Patent.
National validation of a European Patent remains appropriate in several scenarios. First, where the applicant wants coverage only in a small number of specific countries: if protection is needed only in Germany, France, and the Netherlands, national validation in those three countries may be cheaper than a Unitary Patent covering 18 member states with a correspondingly higher renewal fee. Second, where the applicant wants to include non-UPC countries in the core strategy: if Switzerland, the UK, or Norway are important markets, national validation in those countries is required regardless of the unitary effect decision, and the applicant may prefer to manage the entire portfolio through national validation for consistency. Third, where the applicant has concerns about the UPC itself: the UPC's centralised revocation jurisdiction means that a successful invalidity attack on a Unitary Patent revokes it across all participating member states simultaneously, whereas a nationally validated EP can only be revoked country by country. Applicants with strong patents in contested technology areas may prefer the country-by-country revocation risk profile of national validation.
Yes. During a transitional period (initially seven years, extendable to fourteen), proprietors of granted European Patents and applicants for European Patents can opt out of the UPC's jurisdiction. An opted-out patent is subject to national courts only, as under the pre-UPC system. The opt-out must be filed with the UPC before any UPC action is commenced on the patent. Once a UPC action has been commenced, the opt-out right is lost for that patent. Opt-outs can be withdrawn (opted back in) at any time, provided no national action has been commenced on the patent after the opt-out was filed.
The sunrise period was a three-month window (1 March to 31 May 2023) before the UPC and Unitary Patent system became operational on 1 June 2023, during which proprietors of existing European Patents could file opt-outs without any UPC action having commenced. The sunrise period is closed and no longer operative. However, the ongoing opt-out mechanism remains available for all existing and future European Patents, subject to the rule that opt-outs cannot be filed after a UPC action has been commenced.
During a transitional period, a Unitary Patent must be filed with a translation: where the EP was granted in English, a translation into any other EU official language is required; where the EP was granted in French or German, a translation into English is required. After the transitional period (currently expected to be six years from the entry into force of the translation regulation), no translation will be required. This is a significant reduction in the translation cost burden compared to national validation, where each country typically requires a translation of the patent into the national language for validation purposes.
%402x.svg){kind=icon}
%402x.svg){kind=small}
%402x.svg){kind=icon}
